AAAAAA

   
Results: 1-25 |
Results: 25

Authors: KUNG LL CONLEY R CHUTE DJ SMIALEK J ROBERTS RC
Citation: Ll. Kung et al., SYNAPTIC CHANGES IN THE STRIATUM OF SCHIZOPHRENIC CASES - A CONTROLLED POSTMORTEM ULTRASTRUCTURAL-STUDY, Synapse, 28(2), 1998, pp. 125-139

Authors: CONLEY R
Citation: R. Conley, THE COMMERCIAL SECTOR - MARKETING DIET AND FITNESS RESPONSIBLY, International journal of obesity, 22, 1998, pp. 55-58

Authors: CONLEY R KELLY D LOVE R
Citation: R. Conley et al., RISPERIDONE USE IN MARYLAND - DOSING TRENDS AND REHOSPITALIZATION RATES, Biological psychiatry, 43, 1998, pp. 399-399

Authors: ROSS DE THAKER GK BUCHANAN RW LAHTI AC CONLEY R MEDOFF D
Citation: De. Ross et al., SPECIFIC MEASURES ACCOUNT FOR MOST OF THE VARIANCE IN QUALITATIVE RATINGS OF SMOOTH-PURSUIT EYE-MOVEMENTS IN SCHIZOPHRENIA, Archives of general psychiatry, 55(2), 1998, pp. 184-185

Authors: CONLEY R GOUNARIS C
Citation: R. Conley et C. Gounaris, DEMOGRAPHIC DIFFERENCES IN OLANZAPINE RESPONDERS WITH THERAPY-REFRACTORY SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 189-190

Authors: CONLEY R GALE E HIRSCH K
Citation: R. Conley et al., OLANZAPINE RESPONSE IN THERAPY-REFRACTORY SCHIZOPHRENIA WITH SUBSTANCE-ABUSE (SA), Schizophrenia research, 24(1-2), 1997, pp. 190-190

Authors: LINGLE JS PESZKE MA KENT D CONLEY R
Citation: Js. Lingle et al., THE EFFICACY OF OLANZAPINE TREATMENT IN PATIENTS PREVIOUSLY TREATED WITH CLOZAPINE, Schizophrenia research, 24(1-2), 1997, pp. 190-190

Authors: RICHARDSON C CONLEY R
Citation: C. Richardson et R. Conley, OLANZAPINE RESPONSE IN SCHIZOPHRENIC SUBJECTS WITH NEUROLEPTIC RESISTANT DISORGANIZATION, Schizophrenia research, 24(1-2), 1997, pp. 191-191

Authors: KRAMER MS LAST B GETSON A REINES SA SILVA JA WIRSHING W CONLEY R ALLAN E CHENG HY CHAVEZENG C
Citation: Ms. Kramer et al., THE EFFECTS OF A SELECTIVE D-4 DOPAMINE-RECEPTOR ANTAGONIST (L-745,870) IN ACUTELY PSYCHOTIC INPATIENTS WITH SCHIZOPHRENIA, Archives of general psychiatry, 54(6), 1997, pp. 567-572

Authors: ROBERTS RC CONLEY R KUNG LL PERETTI FJ CHUTE DJ
Citation: Rc. Roberts et al., REDUCED STRIATAL SPINE SIZE IN SCHIZOPHRENIA - A POSTMORTEM ULTRASTRUCTURAL-STUDY, NeuroReport, 7(6), 1996, pp. 1214-1218

Authors: KRAMER M ZIMBROFF D LAST B GETSON A HAFEZ H ALPERT M ROTROSEN J MCEVOY J KANE J MERIDETH C SILVA A ERESHEFSKY L MARDER S CONLEY R ALLAN E KRONIG M AMES D WIRSHING W CHAVEZENG C CHENG HY REINES S
Citation: M. Kramer et al., THE EFFECTS OF A SELECTIVE D-4 ANTAGONIST (L-745,870) IN ACUTELY PSYCHOTIC SCHIZOPHRENIC-PATIENTS, Psychopharmacology bulletin, 32(3), 1996, pp. 467-467

Authors: SICA D FAKHRY I GHOSH S FOX A CONLEY R WEBER J RIPLEY E GEHR T
Citation: D. Sica et al., A NOVEL ANALYTICAL METHOD FOR THE DETERMINATION OF ANGIOTENSIN-II, Clinical chemistry, 42(6), 1996, pp. 565-565

Authors: CONLEY R ZHAO M WONG D TAMMINGA C
Citation: R. Conley et al., C-11 NMSP RECEPTOR OCCUPANCY BY CLOZAPINE AND HALOPERIDOL IN SCHIZOPHRENIC SUBJECTS, Biological psychiatry, 39(7), 1996, pp. 53-53

Authors: CONLEY R DAVISS S GOUNARIS C TAMMINGA C
Citation: R. Conley et al., CAVUM SEPTUM PELLUCIDUM (CSP) IN TREATMENT-RESISTANT SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 26-26

Authors: LAHTI RA CONLEY R GRUBOWSKI L TAMMINGA CA
Citation: Ra. Lahti et al., DISTRIBUTION OF DOPAMINE D2, D3 AND D4 RECEPTORS IN HUMAN POSTMORTEM BRAIN SECTIONS, Schizophrenia research, 15(1-2), 1995, pp. 63-63

Authors: CONLEY R MEDOFF D WONG D TAMMINGA C
Citation: R. Conley et al., C-11 NMSP RECEPTOR OCCUPANCY BY CLOZAPINE AND HALOPERIDOL IN SCHIZOPHRENIC SUBJECTS, Schizophrenia research, 15(1-2), 1995, pp. 80-80

Authors: GALE E HIRSCH K KENT D CONLEY R
Citation: E. Gale et al., CLOZAPINE RESPONSE IN TREATMENT-RESISTANT SCHIZOPHRENICS WITH SUBSTANCE-ABUSE, Schizophrenia research, 15(1-2), 1995, pp. 150-151

Authors: CONLEY R GOUNARIS C ZAREMBA S
Citation: R. Conley et al., RWJ-37796, A NOVEL COMPOUND IN THE TREATMENT OF SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 152-152

Authors: RICHARDSON C CONLEY R
Citation: C. Richardson et R. Conley, CLOZAPINE RESPONSE IN SCHIZOPHRENIC SUBJECTS WITH NEUROLETPIC RESISTANT DISORGANIZATION, Schizophrenia research, 15(1-2), 1995, pp. 162-163

Authors: ZAREMBA S MCMULLAN R DORER G CONLEY R
Citation: S. Zaremba et al., PATIENT EDUCATION OF PSYCHOTIC SUBJECTS TO OBTAIN INFORMED CONSENT, Schizophrenia research, 15(1-2), 1995, pp. 223-223

Authors: CONLEY R RICHARDSON C KENT D GOUNARIS C ZAREMBA S
Citation: R. Conley et al., CLOZAPINE RESPONSE VARIES IN DEFICIT VS NON-DEFICIT SCHIZOPHRENIC SUBJECTS, Biological psychiatry, 35(9), 1994, pp. 746-746

Authors: CONLEY R TAMMINGA CA NGUYEN JA
Citation: R. Conley et al., CLINICAL ACTION OF REMOXIPRIDE, Archives of general psychiatry, 51(12), 1994, pp. 1001-1001

Authors: DIXON L THAKER G CONLEY R ROSS D CASCELLA N TAMMINGA C
Citation: L. Dixon et al., CHANGES IN PSYCHOPATHOLOGY AND DYSKINESIA AFTER NEUROLEPTIC WITHDRAWAL IN A DOUBLE-BLIND DESIGN, Schizophrenia research, 10(3), 1993, pp. 267-271

Authors: DIXON L DIBIETZ E MYERS P CONLEY R MEDOFF D LEHMAN AF
Citation: L. Dixon et al., COMPARISON OF DSM-III-R DIAGNOSES AND A BRIEF INTERVIEW FOR SUBSTANCEUSE AMONG STATE-HOSPITAL PATIENTS, Hospital & community psychiatry, 44(8), 1993, pp. 748-752

Authors: LAHTI AC CONLEY R LAHTI RA CARLSSON A TAMMINGA CA
Citation: Ac. Lahti et al., PHARMACOLOGY AND EFFICACY OF (-)-3PPP IN SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 33(6A), 1993, pp. 68-68
Risultati: 1-25 |